152128-77-3: Emtricitabine Sulfoxide (Mixture of Diastereomer)

152128-77-3: Emtricitabine Sulfoxide (Mixture of Diastereomer)

Emtricitabine Sulfoxide Impurity (CAS No.152128-77-3) is a nucleoside reverse transcriptase inhibitor (NRTI) in combination with other antiviral agents it shows activity against HIV. It is approved for use in combination therapy.

Additional information on CAS 152128-77-3

Catalogue No.

VL54003
CAS No.

152128-77-3
Molecular Formula

C8H10FN3O4S
Molecular Weight

263.25
Parent drug

Emtricitabine
IUPAC Name

4-Amino-5-fluoro-1-[(2R,3RS,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl]-2(1H)-Pyrimidinone
Synonyms

Emtricitabine S-Oxide Impurity; Emtricitabine IP Impurity H; 4-Amino-5-fluoro-1-[(2R, 5S)-2-(hydroxymethyl)-3-oxido-1, 3-oxathiolan-5-yl]-2(1H)-pyrimidinone; [2R-(2?, 5?)]-4-Amino-5-fluoro-1-[2-(hydroxymethyl)
References

'Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https://doi.org/10.1016/s0140-6736(17)32340-1. Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://do
Status

In-stock

Other products related to emtricitabine

[rfq_list]

Login first to add product to RFQ List

Request a quote

152128-77-3: Emtricitabine Sulfoxide (Mixture of Diastereomer)

152128-77-3: Emtricitabine Sulfoxide (Mixture of Diastereomer)
Catalogue No.

VL54003
CAS No.

152128-77-3
Molecular Formula

C8H10FN3O4S
Molecular Weight

263.25
Parent drug

Emtricitabine
IUPAC Name

4-Amino-5-fluoro-1-[(2R,3RS,5S)-2-(hydroxymethyl)-3-oxido-1,3-oxathiolan-5-yl]-2(1H)-Pyrimidinone
Synonyms

Emtricitabine S-Oxide Impurity; Emtricitabine IP Impurity H; 4-Amino-5-fluoro-1-[(2R, 5S)-2-(hydroxymethyl)-3-oxido-1, 3-oxathiolan-5-yl]-2(1H)-pyrimidinone; [2R-(2?, 5?)]-4-Amino-5-fluoro-1-[2-(hydroxymethyl)
References

'Sax, Paul E., et al. “Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide versus Dolutegravir with Emtricitabine and Tenofovir Alafenamide, for Initial Treatment of HIV-1 Infection (GS-US-380–1490): A Randomised, Double-Blind, Multicentre, Phase 3, Non-Inferiority Trial.” The Lancet, vol. 390, no. 10107, Nov. 2017, pp. 2073–82, https://doi.org/10.1016/s0140-6736(17)32340-1. Bang, Lynne M., and Lesley J. Scott. “Emtricitabine.” Drugs, vol. 63, no. 22, 2003, pp. 2413–24, https://do
Status

In-stock
ListName

Emtricitabine Sulfoxide (Mixture of Diastereomer)
Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden